Delivery Order SPE2DB20D3103-SPE2DB25FN8C1

Award Date 5/13/25
Potential Completion Date 5/14/25
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order with a firm fixed price valued at $3,224.81. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MUPIROCIN 2% CREAM 15GM, a pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MUPIROCIN 2% CREAM 15GM, a pharmaceutical product, with a ceiling value of $1,564.08 and a period of performance through June 13, 2025. The contract is not set-aside and is awarded as a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $1,970.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MUPIROCIN 2% CREAM 15GM, a pharmaceutical product, and is a firm fixed-price delivery order with a completion date of May 9, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
The federal contract award, valued at $1,213.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MUPIROCIN 2% CREAM 15GM, a pharmaceutical product, with a period of performance ending on October 31, 2023. This contract award is not designated as a set-aside and is a firm-fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,231.26 firm-fixed-price delivery order is for the supply of 4562879853 - MUPIROCIN 2% CREAM 15GM, with a period of performance through November 22, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,173.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565298107 - MUPIROCIN 2% CREAM 15GM, with a completion date of July 31, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with any set-aside requirements. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,520.77 firm fixed-price delivery order is for the supply of MUPIROCIN 2% CREAM 15GM, a topical antibiotic medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of MUPIROCIN 2% CREAM 15GM, a pharmaceutical product, with a ceiling value of $1,851.56 and a performance period ending on May 30, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6LKK, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,666.95 firm fixed-price delivery order is for the supply of MUPIROCIN 2% CREAM 15GM, a medical product, with an ultimate completion date of April 3, 2025. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,525.54 Firm Fixed Price Delivery Order is for the supply of MUPIROCIN 2% CREAM 15GM, a pharmaceutical product. The contract has a completion date of September 20, 2023. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the federal government - a $999,999,999 IDC with the DLA Troop Support...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN8C1
    Delivery Order

This federal contract award, valued at $3,128.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4568236646 - MUPIROCIN 2% CREAM 15GM. The contract is a Firm Fixed Price Delivery Order with a performance period through May 14, 2025.

The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This award is likely a discrete delivery order issued against that larger IDC, enabling the company to supply a variety of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/12/25, 11:55 AM